| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/CCO.0B013E32834D8155 |
| P698 | PubMed publication ID | 22123231 |
| P50 | author | Jean-François Tanti | Q57320836 |
| Frédéric Bost | Q58841110 | ||
| P2093 | author name string | Yannick Le Marchand-Brustel | |
| Issam Ben Sahra | |||
| P433 | issue | 1 | |
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 103-108 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Current Opinion in Oncology | Q1909046 |
| P1476 | title | Metformin and cancer therapy | |
| P478 | volume | 24 |
| Q26830077 | Adipocytes: impact on tumor growth and potential sites for therapeutic intervention |
| Q36021012 | Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells |
| Q37588301 | Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport |
| Q36152361 | Cancer risk in HBV patients with statin and metformin use: a population-based cohort study. |
| Q38121736 | Clinical management of obese patients with cancer |
| Q38867200 | Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma |
| Q38167147 | Complications of diabetes therapy. |
| Q37299288 | Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin |
| Q36215473 | Early treatment with metformin induces resistance against tumor growth in adult rats |
| Q100548710 | Effect of Vitamin E on Cisplatin-induced Memory Impairment in Male Rats |
| Q34432841 | Effects of metformin on retinoblastoma growth in vitro and in vivo. |
| Q36394649 | EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer |
| Q38244345 | Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin |
| Q34390494 | Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways |
| Q35615701 | Investigational cancer drugs targeting cell metabolism in clinical development |
| Q24626229 | Links between metabolism and cancer |
| Q37015746 | Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin |
| Q38381446 | Local adipocyte cancer cell paracrine loop: can "sick fat" be more detrimental? |
| Q36209145 | Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs |
| Q37619208 | Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice |
| Q28551025 | Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice |
| Q36131775 | Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients. |
| Q50105959 | Metformin and cancer: An existing drug for cancer prevention and therapy |
| Q36545028 | Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo |
| Q28486318 | Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners |
| Q37642352 | Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy |
| Q35828675 | Metformin potentiates rapamycin and cisplatin in gastric cancer in mice |
| Q53378831 | Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells. |
| Q39721653 | Metformin use and asthma outcomes among patients with concurrent asthma and diabetes |
| Q36021086 | Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells |
| Q38976395 | Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients |
| Q36436404 | Metformin: Midlife maturity, maiden charm |
| Q34782184 | Miniature short hairpin RNA screens to characterize antiproliferative drugs |
| Q92920996 | Novel Metformin-Based Schiff Bases: Synthesis, Characterization, and Antibacterial Evaluation |
| Q36620705 | Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β) protein attenuates vascular lesion formation by inhibition of chromatin loading of minichromosome maintenance complex in smooth muscle cells |
| Q34766688 | Repositioning of Verrucosidin, a purported inhibitor of chaperone protein GRP78, as an inhibitor of mitochondrial electron transport chain complex I. |
| Q36947847 | Synergic chemoprevention with dietary carbohydrate restriction and supplementation of AMPK-activating phytochemicals: the role of SIRT1 |
| Q39027675 | Targeting Inflammation in Cancer Prevention and Therapy |
| Q38017727 | Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies |
| Q33895001 | The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells. |
| Q36776406 | Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism |
| Q28483867 | Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer |
| Q36618612 | Tumors and their stroma: mitochondria at the crossroad |
Search more.